News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Arrowhead Pharmaceuticals, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
Deals
Promising Hep B Drug Makes SoCal’s Arrowhead Pharma a Pretty Target for Gilead and Other Big Companies
April 15, 2016
·
2 min read
Deals
Novartis AG Unloads RNAi Portfolio to Arrowhead Research Corporation for $35 Million
March 5, 2015
·
3 min read
Deals
Arrowhead Research Corporation Soars on Rumor of Gilead Sciences, Inc.'s Interest
December 31, 2014
·
2 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Biotech Beach
Arrowhead Pharmaceuticals Presents New Clinical Data Showing ARO-RAGE Achieves High Level of Gene Knockdown in Patients with Asthma
May 20, 2024
·
8 min read
Business
Arrowhead Pharmaceuticals Reports Fiscal 2024 Second Quarter Results
May 9, 2024
·
10 min read
Biotech Beach
Arrowhead Pharmaceuticals Earns $50 Million Milestone from Royalty Pharma
May 2, 2024
·
6 min read
Biotech Beach
Arrowhead Pharmaceuticals to Participate in Upcoming May 2024 Conferences
April 29, 2024
·
6 min read
Biotech Beach
Arrowhead Pharmaceuticals to Host 2024 Summer Series of R&D Webinars
April 26, 2024
·
5 min read
Business
Arrowhead Pharmaceuticals to Webcast Fiscal 2024 Second Quarter Results
April 24, 2024
·
4 min read
Drug Development
Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-CFB for Treatment of Complement Mediated Kidney Disease
April 24, 2024
·
5 min read
Drug Development
Arrowhead Pharmaceuticals Announces New Phase 2 Data of Plozasiran Published in JAMA Cardiology and Presented at American College of Cardiology 73rd Annual Scientific Session & Expo
April 7, 2024
·
10 min read
Biotech Beach
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - April 01, 2024
April 1, 2024
·
4 min read
Biotech Beach
Arrowhead Pharmaceuticals Initiates Expanded Access Program for Plozasiran and Announces Upcoming Presentation of Clinical Data
March 25, 2024
·
7 min read
